While the results indicated an overall decrease in c-reactive protein (CRP) in treated individuals with PAH, pulmonary vascular resistance remained unaffected, and right ventricle function was not measured (Study #5) [193]. The gene discussed is CRP; the disease is pulmonary arterial hypertension.